期刊文献+

去甲斑蝥素对人未分化甲状腺癌FRO细胞迁移、侵袭影响及机制研究 被引量:3

Study on the effects of norcantharidin on the migration and invasion of human undifferentiated thyroid carcinoma FRO cells and its mechanism
下载PDF
导出
摘要 目的探讨去甲斑蝥素对人未分化甲状腺癌FRO细胞迁移、侵袭能力及机制研究。方法取对数生长期的人未分化甲状腺癌FRO细胞,加入不同浓度的去甲斑蝥素(2.5,5,10,20,40,80μg/mL)处理12 h、24 h和48 h,采用CCK-8法检测细胞增殖抑制情况。取对数生长期的人未分化甲状腺癌FRO细胞,分为空白组、10μg/mL去甲斑蝥素组、20μg/mL去甲斑蝥素组、40μg/mL去甲斑蝥素组,各组培养24 h后,采用划痕实验和Transwell实验检测FRO细胞的迁移和侵袭能力,流式细胞术检测细胞周期,TUNEL法检测细胞凋亡情况,Western blot法检测转移相关蛋白E-钙黏蛋白(E-cadherin)、基质金属蛋白酶-9(MMP-9)表达水平。结果2.5,5,10,20,40,80μg/mL的去甲斑蝥素对FRO细胞均有明显的增殖抑制作用,呈剂量时间依赖性。10μg/mL去甲斑蝥素组、20μg/mL去甲斑蝥素组、40μg/mL去甲斑蝥素组FRO细胞的迁移和侵袭能力均逐渐减弱,G2/M期细胞逐渐增多,细胞凋亡率逐渐增高,E-cadherin表达量逐渐增高,MMP-9表达量逐渐降低,各组间两两比较差异均有统计学意义(P均<0.05)。结论去甲斑蝥素能够抑制人未分化甲状腺癌FRO细胞的增殖、迁移和侵袭,并可诱导细胞周期阻滞,促进细胞凋亡,其机制可能与上调E-cadherin和下调MMP-9蛋白表达有关。 Objective It is to explore the effects of norcantharidin on the migration and invasion of human undifferentiated thyroid carcinoma FRO cells and its mechanism.Methods The human undifferentiated thyroid cancer FRO cells in the logarithmic growth phase were taken and cultured with different concentrations of norcantharidin(2.5,5,10,20,40,80μg/mL)for 12 h,24 h and 48 h,the cell proliferation inhibition was detected by CCK-8 method.The human undifferentiated thyroid cancer FRO cells in the logarithmic growth phase were taken and divided into blank group,10μg/mL norcantharidin group,20μg/mL norcantharidin group,40μg/mL norcantharidin group,each group was cultured for 24 h,the migration and invasion ability of FRO cells were detected by the scratch test and the Transwell test,the cell cycle was detected by flow cytometry,the apoptosis was detected by the TUNEL method,and the expression levels of transfer-associated protein E-cadherin(E-cadherin),matrix metalloproteinase-9(MMP-9)was detected by Western blot.Results 2.5,5,10,20,40,80μg/mL norcantharidin had a significant proliferation inhibitory effect on FRO cells,which was dose-time dependent.The migration and invasion ability of FRO cells in the 10μg/mL norcantharidin group,20μg/mL norcantharidin group,and 40μg/mL norcantharidin group gradually weakened,and the number of cells in the G2/M phase gradually increased,and the apoptosis rate gradually increased,the expression of E-cadherin gradually increased,and the expression of MMP-9 gradually decreased,there were statistically significant differences between every two groups(all P<0.05).Conclusion Norcantharidin can inhibit the proliferation,migration and invasion of human undifferentiated thyroid cancer FRO cells,and can induce cell cycle arrest and promote cell apoptosis.The mechanism may be related to the up-regulation of E-cadherin and down-regulation of MMP-9 protein expression.
作者 许景伟 樊丽 岳丽玲 许瀚文 XU Jingwei;FAN Li;YUE Liling;XU Hanwen(The First Affiliated Hospital of Qiqihar Medical College,Qiqihaer 161041,Heilongjiang,China;Institute of Medical Sciences of Qiqihar Medical College,Qiqihaer 161006,Heilongjiang,China;THe Clinical Medical College of Tianjin Medical University,Tianjin,300270,China)
出处 《现代中西医结合杂志》 CAS 2021年第21期2285-2289,共5页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 黑龙江省省属高等学校基本科研业务费科研项目(2017-QYKYYWF-0757)。
关键词 去甲斑蝥素 FRO细胞 迁移 侵袭 E-钙黏蛋白 基质金属蛋白酶-9 norcantharidin FRO cells migration invasion E-cadherin MMP9
  • 相关文献

参考文献6

二级参考文献50

  • 1范跃祖,傅锦业,赵泽明,陈春球.去甲斑蝥素对人胆囊癌GBC-SD细胞系生长及侵袭的影响[J].中国中西医结合杂志,2004,24(S1):180-183. 被引量:3
  • 2Fan, Yue-Zu,Fu, Jin-Ye,Zhao, Ze-Ming,Chen, Chun-Qiu.Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):72-80. 被引量:25
  • 3郑英兰,史春雷,贺延新.去甲斑蝥素治疗肝癌的临床研究[J].河北医学,2005,11(9):820-821. 被引量:11
  • 4周文丽,考军,范清玲.去甲斑蝥素片辅助治疗胃肠道癌肝转移30例临床观察[J].山东医药,2005,45(20):32-33. 被引量:4
  • 5Kebebew E,Greenspan FS,Clark OH,et al.Anaplastic thyroid carcinoma.Treatment outcome and prognostic factors[J].Cancer,2005,103(7):1330-1335.
  • 6Simon D,Korber C,Krausch M,et al.Clinical impact of retinoids in redifferentiadon therapy of advanced thyroid cancer:final results of a pilot study[J].Eur J Nucl Med Mol Imaging,2002,29(6):775-782.
  • 7Nagayama,Y,Nishihara E,Namba H,et al.Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system[J].Cancer Gene Ther,2001,8(1):36-44.
  • 8Kim SB,Ahn IM,Park HJ,et al.Growth inhibition and chemosensitivity of poorly differentiated human thyroid cancer cell line (NPA) transfected with p53 gene[J].Head Neck,2001,23(3):223-229.
  • 9Takeda T,Inaba H,Yamazaki M,et al.Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter[J].Clin Endocrinol Metab,2003,8818):3531-3538.
  • 10Barzon L,Pacenti M,Taccaliti A,et al.A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma[J].J Clin Endocrinol Metab,2005,90(5):2831-2834.

共引文献103

同被引文献67

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部